Published in Arq Bras Cardiol on November 01, 1987
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia (2009) 2.30
Granulocyte colony-stimulating factor following peripheral-blood progenitor-cell transplant in non-Hodgkin's lymphoma. J Clin Oncol (1995) 1.42
Bacterial endocarditis produced by Listeria monocytogenes. Case presentation and review of literature. Am J Clin Pathol (1975) 1.29
Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone. Br J Haematol (2001) 1.20
Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol (1993) 1.09
Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood (1989) 1.08
T cell receptor beta chain gene rearrangements in lymphoproliferative disorders of large granular lymphocytes/natural killer cells. J Exp Med (1985) 1.07
Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Br J Haematol (1999) 1.07
Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis. J Clin Oncol (1989) 1.02
KM+, a mannose-binding lectin from Artocarpus integrifolia: amino acid sequence, predicted tertiary structure, carbohydrate recognition, and analysis of the beta-prism fold. Protein Sci (1999) 0.92
Is female sex an independent predictor of in-hospital mortality in acute myocardial infarction? Arq Bras Cardiol (2001) 0.89
Transcriptional and post-transcriptional regulation of IL-1 beta, IL-6 and TNF-alpha genes in chronic lymphocytic leukaemia. Br J Haematol (1993) 0.85
Large granular lymphocyte/natural killer cell proliferative disease: clinical and laboratory heterogeneity. Scand J Haematol (1986) 0.84
[The sinus node in chronic Chagas cardiopathy]. Arq Bras Cardiol (1983) 0.84
Atrioventricular block in acute inferior wall myocardial infarction: harbinger of associated obstruction of the left anterior descending coronary artery. J Am Coll Cardiol (1986) 0.84
Expansion of B cell precursors after unrelated cord blood transplantation for an adult patient. Bone Marrow Transplant (2007) 0.84
CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint. Leukemia (1995) 0.83
Expression of leukocyte alkaline phosphatase gene in normal and leukemic cells: regulation of the transcript by granulocyte colony-stimulating factor. Blood (1990) 0.83
Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function. Eur J Cancer Clin Oncol (1983) 0.83
Interaction between a serum factor and T lymphocytes in Gaucher disease. Am J Hematol (1985) 0.82
Differences in the expression of alkaline phosphatase mRNA in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria polymorphonuclear leukocytes. Blood (1989) 0.82
Myelokathexis: a rare form of chronic benign granulocytopenia. Br J Haematol (1984) 0.81
Platelet function after busulphan in chronic myeloproliferative disorders. Haematologica (1983) 0.80
Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphoma. Haematologica (1997) 0.80
Cancer procoagulant in acute lymphoblastic leukemia. Eur J Haematol (1990) 0.80
Characteristics of secondary acute lymphoblastic leukemia with L3 morphology in adult patients. Leuk Lymphoma (2002) 0.80
Short-term therapy for acute myelogenous leukemia. J Clin Oncol (1988) 0.79
Danazol for the treatment of idiopathic thrombocytopenic purpura. Acta Haematol (1985) 0.79
Subvalvular left ventricular pseudoaneurysm: a rare complication of mitral valve replacement. Cathet Cardiovasc Diagn (1981) 0.79
Factors for rapid and sustained hematopoietic reconstitution by circulating progenitor-cell transplantation in non-Hodgkin's lymphoma. Cancer Chemother Pharmacol (1996) 0.78
Short-term remission induction and consolidation therapy for adult acute myelogenous leukemia. Hematol Oncol (1991) 0.78
Concurrent multiple myeloma and chronic lymphocytic leukemia. Am J Clin Pathol (1984) 0.78
Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity. Thromb Haemost (1990) 0.78
Induction of cytotoxicity by interleukin-2 in T gamma-lymphoproliferative disorders. Int J Cancer (1986) 0.77
Pure white cell aplasia treated by high dose intravenous immunoglobulin. Br J Haematol (1984) 0.77
Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia. Leukemia (2003) 0.77
Laser channels after percutaneous transmyocardial revascularization. Circulation (1999) 0.77
Multiple myeloma in a pair of twins. Br J Haematol (1987) 0.76
High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia. Ann Oncol (2000) 0.76
Conventional dose cytosine arabinoside in combination chemotherapy for acute myelogenous leukemia. Semin Oncol (1987) 0.76
[Hospital outcome and short-term follow-up of elderly patients presenting to the emergency unit with congestive heart failure]. Arq Bras Cardiol (1998) 0.76
Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia. Leuk Lymphoma (1996) 0.75
Institutional performance and dose intensity as prognostic factors in adult ALL. Leukemia (1995) 0.75
High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia. Br J Cancer (1990) 0.75
Intensive chemotherapy for acute lymphoblastic leukaemia in adults. Haematol Blood Transfus (1990) 0.75
Randomized clinical trials in adult acute lymphoblastic leukemia: which is the question? Haematologica (1998) 0.75
[Agenesis of the inferior vena cava with venous drainage by the azygous vein. Report of a case]. Arq Bras Cardiol (1970) 0.75
Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cells. Leuk Lymphoma (1999) 0.75
[Cardiac performance in acute aortic insufficiency]. Arq Bras Cardiol (1980) 0.75
[Torsades de Pointes: analysis of 105 episodes]. Arq Bras Cardiol (1991) 0.75
Migratory capacity of large granular lymphocytes from T-gamma-lymphoproliferative disorders. Nat Immun Cell Growth Regul (1986) 0.75
Platelet malonyldialdehyde and spontaneous aggregation during ischaemic attacks of patients with polycythaemia vera. Thromb Haemost (1979) 0.75
[Registration of an anomalous pathway potential in a patient with ventricular pre-excitation. A case report]. Arq Bras Cardiol (1984) 0.75
Surface immunoglobulin intensivity and p67 (CD5) antigen expression define different forms of B-cell chronic lymphocytic leukaemia. Haematologica (1987) 0.75
Bleeding and thrombosis in acute lymphoblastic leukemia. Leuk Lymphoma (1993) 0.75
[Natural history of survivors of acute myocardial infarction. Prospective study and ergometric and angiographic correlations]. Arq Bras Cardiol (1986) 0.75
[The importance of valve dysfunction in atrioventricular canal defects]. Arq Bras Cardiol (1980) 0.75
[Ventricular circumferential stress and its telesystolic relations in ischemic heart disease. Simple alternatives for its evaluation]. Arq Bras Cardiol (1988) 0.75
Treatment of acute lymphoblastic leukemia in adults. Hematol Oncol (1985) 0.75
[Use of artificial pacemaker in the evaluation of heart function in coronary diseases]. Arq Bras Cardiol (1976) 0.75
Long-term haematological reconstitution following BEAM and autologous transplantation of circulating progenitor cells in non-Hodgkin's lymphoma. Br J Haematol (1997) 0.75
Abnormal aggregation and increased size of platelets in myeloproliferative disorders. Thromb Haemost (1980) 0.75
Translocation (8;21) in two cases of refractory anemia with excess of blasts in transformation. Cancer Genet Cytogenet (1992) 0.75
[Arrhythmogenic right ventricular dysplasia]. Arq Bras Cardiol (1991) 0.75
[Mitral and tricuspid valvuloplasty with balloon catheterization in the same procedure. A case report]. Arq Bras Cardiol (1989) 0.75
In vitro treatment of bone marrow from patients with T-cell acute lymphoblastic leukemia and non-Hodgkin's lymphoma using the immunotoxin WT1-ricin A. Haematol Blood Transfus (1987) 0.75
RAEB in a patient with chronic granulated T-lymphocytosis. Br J Haematol (1987) 0.75
[The elderly patient with coronary disease: is it worth to remove obstructions?]. Arq Bras Cardiol (1991) 0.75
Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases. Thromb Haemost (1982) 0.75
Thrombotic thrombocytopenic purpura and high-dose immunoglobulin treatment. Ann Intern Med (1986) 0.75
[Coronary cineangiography in survivors of acute myocardial infarction: is it really necessary?]. Arq Bras Cardiol (1987) 0.75
Retrospective analysis of treatment of acute myeloblastic leukemia in patients more than 55 years old. Acta Haematol (1982) 0.75
Lymphokine production in T gamma lymphoproliferative disorders. Scand J Immunol (1986) 0.75
Constitutive expression of IL-1 beta, M-CSF and c-fms during the myeloid blastic phase of chronic myelogenous leukaemia. Br J Haematol (1992) 0.75
Spectrum of platelet aggregation abnormalities in myeloproliferative diseases. Ric Clin Lab (1981) 0.75
Infection and hemorrhage in elderly acute myeloblastic leukemia and primary myelodysplasia. Hematol Oncol (1993) 0.75
[Aneurysm of the membranous portion of the interventricular septum]. Arq Bras Cardiol (1976) 0.75
[Left ventricular performance in coronary ventriculography]. Arq Bras Cardiol (1976) 0.75
[Torsades de pointes: analysis of 105 episodes]. Rev Port Cardiol (1993) 0.75
[Coronary anatomy and left ventricular function in patients surviving acute myocardial infarction]. Arq Bras Cardiol (1985) 0.75
[Current concepts on atrioventricular block in acute myocardial infarction of the inferior wall]. Arq Bras Cardiol (1989) 0.75
Prognostic value of junctional recovery times and long-time follow-up of complete atrioventricular nodal block at a young age. Am J Cardiol (1990) 0.75
G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation of resistant or relapsing acute leukemias. Leukemia (1996) 0.75
[Development of the ductus arteriosus in obstructive lesions of the outlet chamber of the right ventricle]. Arq Bras Cardiol (1980) 0.75
[Multisaccular aneurysm at the site of a coarctation of the aorta. Report of a case]. Arq Bras Cardiol (1979) 0.75
[Modified exercise test in the 3d week after acute myocardial infarction. Correlation of coronary cineangiography and follow-up]. Arq Bras Cardiol (1984) 0.75
Echocardiogram in aortic stenosis. Am J Cardiol (1977) 0.75
[Left ventricular performance in the right ventricular overload]. Arq Bras Cardiol (1979) 0.75
[Coronary artery aneurysms in children--coronaritis caused by Kawasaki disease]. Arq Bras Cardiol (1982) 0.75
Long-term outcome of adults with acute myelogenous leukaemia: results of a prospective, randomized study of chemotherapy with a minimal follow-up of 7 years. Br J Haematol (1991) 0.75
Immunological and genotypic analysis of human T gamma-lymphoproliferative disorders. Ric Clin Lab (1986) 0.75
[Cinecoronariography after acute myocardial infarct: for whom?]. Arq Bras Cardiol (1984) 0.75
Short term therapy (STT) for acute myelogenous leukaemia (AML). Leukemia (1992) 0.75
[Cardiac performance in acute mitral insufficiency]. Arq Bras Cardiol (1980) 0.75
Therapeutic efficacy of danazol in myelodysplastic syndromes. Eur J Cancer Clin Oncol (1988) 0.75
Hemodynamic profile of mitral stenosis. Correlation with valve area. Arq Bras Cardiol (1986) 0.75
[Hemodynamic effects of oral disopyramide in patients with acute myocardial infarction]. Arq Bras Cardiol (1982) 0.75
[Angiographic and hemodynamic aspects and natural history of survivors of non-transmural myocardial infarction. Comparison with transmural infarction]. Arq Bras Cardiol (1986) 0.75